Cardiology Online

Home

Welcome

Scientific Committees

Timetable

Program Topics

Advance Program

Opening Lecture

International Academy of Cardiology Awards

IAC Distinguished Fellowship Awards

General Information

Abstract Guidelines

Instructions for the Preparation of Posters

Accommodation

Exhibition

Contact Us

Click here to download List of Scientific Presentations - Advance Program (pdf)

 POSTER HALL

P501    Poster Session
NUCLEAR CARDIOLOGY/ POSITRON EMISSION TOMOGRAPHY/ CARDIAC CT AND MRI

EVALUATION OF CORONARY ARTERY DISEASE COMPLICATED BY THORACIC AORTIC DISEASE BY WIDE-VOLUME SCAN USING 320-ROW CT
K. Morishige, T. Yamawaki, H. Tashiro, St. Mary's Hospital, Kurume, Japan

RELATION OF LEFT ATRIAL BODY AND LEFT ATRIAL APPENDAGE VOLUMES WITH CLINICAL PATTERN OF AF
S. Verma, E. Charaf, N. Garg, Cardiology Consultants, Pensacola, FL, USA

IS IT SAFE TO USE REGADENOSON FOR PHARMACOLOGIC STRESS MYCOCARDIAL PERFUSION IMAGING IN END STAGE RENAL DISEASE PATIENTS ON DIALYSIS? FIRST CLINICAL REPORT OF 12 PATIENTS
Z. Husain, G. Palani, A. Karthikeyan, V. Karthikeyan, K. Ananthasubramaniam St Joseph Mercy Oakland, Pontiac, MI, USA

CT ANGIOGRAPHY AND AORTIC ARCH ATHEROSCLEROSIS
D.J. Capampangan, A. Patel, S.J. Lester, L.A. Pearce, B.M. Demaerschalk, D.W. Dodick, T.E. Kiernan, T.J. Ingall, M.I. Aguilar, Mayo Clinic, Phoenix, AZ, USA

DOES PERIPROCEDURAL MYONECROSIS AFTER MAIN VESSEL STENTING OF CORONARY BIFURCATIONS OCCUR? ASSESSMENT BY MEANS OF MRI DELAYED ENHANCEMENT
A. Michalek, D.I. Vassilev, R.J. Gil, T. Pawlowski, T. Kulawik Central Hospital of the Internal Affairs and Adminstration Ministry, Poland

P502      Poster Session
ACUTE MYOCARDIAL INFARCTION / REPERFUSION THERAPY

EFFECT OF EARLIER DOOR TO BALLOON TIMES ON USE OF ADJUNCTIVE MEDICATIONS, AND RESULTANT PROCEDURAL SUCCESS IN STEMI
J.R. Cook, L.W. Klein, J. Chow, R. Marok, P.J. Stecy, K. Magurany Illinois Masonic Medical Center, Chicago, IL, USA

MECHANISM OF ELECTRICAL STIMULATION-INDUCED PRE- AND POST-CONDITIONING
X. Ren, Y. Liu, M. Tranter, M. Wilhide, T. Forde, L. Haar, K. Jones University of Cincinnati, OH, USA

THROMBUS ASPIRATION IN AMI PATIENTS AFTER SYSTEMIC TLT COMBINED WITH EMERGENCY PCI
D.G. Iosseliani, A.G. Koledinsky, D.G. Gromov, N.V. Kuchkina, R.V. Zeynalov Moscow City Center of Interventional Cardioangiology, Moscow, Russia

NEIGHBORHOOD VARIATION IN RATE OF REVASCULARIZATION AMONG ACUTE MYOCARDIAL INFARCTION PATIENTS IN NEW YORK CITY
A. Negassa, Albert Einstein College of Medicine, Bronx, NY, USA

P503      Poster Session
INTERVENTIONAL CARDIOLOGY II

PREDICTORS OF CORONARY INTERVENTION-RELATED MYOCARDIAL INFARCTION IN STABLE ANGINA PATIENTS PRETREATED WITH STATINS
J. Veselka, P. Hajek, M. Maly, D. Zemanek, R. Adlova, D. Tesar, L. Martinkovicova, P. Tomasov, CardioVascular Center, University Hospital Motol, Prague, Czech Republic

OUTCOMES OF PCI IN NONAGENARIANS
C.N. Ionescu, M. Amuchastegui, S.C. Ionescu, C.B. Marcu, A. Ghantous, S. Reddy, Hospital of Saint Raphael, New Haven, CT, USA

CLINICAL AND ELECTROCARDIOGRAPHIC CORRELATES OF NORMAL CORONARY ANGIOGRAPHY IN PATIENTS REFERED FOR PRIMARY PERCUTANEOUS CORONARY INTERVENTION
S.B. Prasad, D.A. Richards, N. Sadick, A.T. Ong, A. Narayan, P. Kovoor Westmead Hospital, Sydney, Australia

IMPACT OF RISK FACTORS ON VASCULAR COMPLICATIONS AFTER PRECUTANEOUS CORONARY INTERVENTIONS IN SHAHEED RAJAEE HEART CENTER
A.A. Yusefi, H. Farshidi, M. Madani, F. Shakeryan, H.R. Sanati, A. Firoozi, N. Salehi, Hormozgan University, Bandar Abbass, Hormozgan, Iran

THE FACTORS ASSOCIATED WITH STENOSIS DEGREE IN CORONARY BIFURCATIONS INFLUENCE RESTENOSIS RATES AFTER SINGLE STENT IMPLANTATION IN CORONARY BIFURCATION LESIONS
D.I. Vassilev, R.J. Gil, A. Michalek, T. Kulawik, T. Pawlowski Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland

LONG-TERM FOLLOW UP OF PATIENTS TREATED WITH PACLITAXEL-ELUTING STENTS WITH BIOSTABLE POLYMER VERSUS BIORESORBABLE POLYMER
L.A. Inigo-Garcia, C. Medina-Palomo, T. Gil-Jimenez, O. Sanz-Vazquez, M. Pombo-Jimenez, J.F. Munoz-Bellido, P. Chinchurreta-Capote, B. Zaya-Ganfornina, J.R. Siles-Rubio, F. Ruiz-Mateas, Hospital Costa del Sol. Marbella, MA, Spain

PERCUTANEOUS CORONARY INTERVENTIONS WITHOUT ON-SITE CARDIAC SURGERY SUPPORT
A. Rahman, J. Haque, S. Rahman, A.R. Khan, K. Asaduzzaman, N. Sabah, A.B. Siddique, Sir Salimullah Medical College, Bangladesh

P504    Poster Session
DIABETES MELLITUS, THE METABOLIC SYNDROME AND ATHEROSCLEROSIS: BASIC AND CLINICAL II

THE EFFECT OF INSULIN ON INTRACELLULAR NA+ HOMEOSTASIS IN ISOLATED CARDIOMYOCYTES FROM DIABETIC RATS
A. Bilginoglu, H.B. Kandilci, B. Turan, Ankara University, Ankara, Turkey

ASSOCIATION OF ADIPONECTIN AND THE HYPERTRIGLYCERIDEMIC-WAIST PHENOTYPE WITH IMPAIRED GLUCOSE TOLERANCE IN WOMEN
J. Methot, Y. Loucif, D. Brisson, D. Gaudet, Université de Montréal, Montréal, Canada

RELATIONSHIP BETWEEN SLEEP QUALITY AND METABOLIC SYNDROME AND INFLAMMATORY MARKERS IN MIDDLE-AGED MEN IN KOREA
J.H. Cho, S.G. Kang, E.J. Lee, S.W. Song, St.Vincent's Hospital, The Catholic University of Korea, Suwon, Gyeonggido, South Korea

ERYTHROCYTE FRAGILITY IS INCREASED IN THE LDL RECEPTOR DEFICIENT MOUSE MODEL
K. Navab, S. Hama, G. Hough, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA

CARDIOVASCULAR HEALTH PROFILE OF PATIENTS ENROLLED IN A CLINIC BASED DIABETES PREVENTION PROGRAM
F.D. Fortuin, C. Kendall, J. Wisbey, R.T. Hurst, S.J. Lester, S.B. Chism, R. Burke, M. Orban, S. Bersoux, C. Cook, Mayo Clinic Arizona, Phoenix, AZ, USA

P505      Poster Session
LIPID, LIPOPROTEIN DISORDERS AND CAD/ TREATMENT OF DYSLIPOPROTEINEMIA II

EXPERIMENTS ON THE MECHANISM OF FORMATION OF THE FATTY ACID HYDROPEROXIDES (HPODE AND HPETE)
D. Golchian, G. Hough, L. Vakili, S. Safarpoor, S. Hama David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA

ANTI-INFLAMMATORY PEPTIDE COMBINATION ADDITIVELY RENDERS CARDIOMYOPATHY PATIENT PLASMA ANTI-INFLAMMATORY
O. Elboudwarej, J.B. Kim, S. Hama, G. Hough, G. Fonarow David Geffen School of Medicine, Los Angeles, CA, USA

ACUTE REDUCTION OF LIPOPROTEIN A FOLLOWING LDL- APHERESIS MAY IMPROVE SYMPTOMS OF ANGINA
D.G. Bulchandani, P. Moriarty, University of Kansas School of Medicine, Kansas City, KS, USA

P506    Poster Session
DILATED CARDIOMYOPATHIES: VARIOUS ETIOLOGIES

QTC AND QT DISPERSION IN MORBID OBESITY: ROLE OF LEFT VENTRICULAR MASS
R. Mukerji, M.A. Alpert, University of Missouri Health Sciences Center, Columbia, MO, USA

THE DETERMINANTS OF RIGHT VENTRICULAR FAILURE IN PATIENTS ADMITTED WITH ACUTE RIGHT HEART FAILURE
R.B. Berkowitz, E. Alhaj, K. Satya, R.B. Manchikalapudi, S. Dadfarmay, Hackensack University Medical Center, Hackensack, NJ, USA

CEREBRAL HEMORRHAGE; PRECIPITATING EVENT FOR A TAKO-TSUBO-LIKE CARDIOMYOPATHY
A.R. Rahimi, M. Katayama, J. Mills, Mercer U. School of Medicine, Savannah, Georgia, USA

P507      Poster Session
DRUG THERAPY IN HEART FAILURE: BASIC AND CLINICAL

SSTR5 AND ß1-AR BLOCKS SST MEDIATED INHIBITION OF cAMP AND SIGNALING IN RECEPTOR SPECIFIC MANNER
R.K. Somvanshi, S.A. War, N. Chaudhari, G. Kharmate, P.S. Rajput, D. Bakshi, X. Qiu, U. Kumar, The University of British Columbia, Vancouver, BC, Canada

MODULATION OF APOPTOTIC AND CALCINEURIN-MEDIATED NFAT DEPHOSPHORYLATION IN CELLS COEXPRESSING SSTR5 AND ß2-AR
R.K. Somvanshi, S.A. War, N. Chaudhari, G. Kharmate, P.S. Rajput, D. Bakshi, X. Qiu, U. Kumar, The University of British Columbia, Vancouver, BC, Canada

TREATMENT WITH L-CARNITINE SIGNIFICANTLY IMPROVES DIASTOLIC HEART FAILURE AND SYMPTOMS
A.R. Serati, M.R. Motamedi, S. Emami, P. Varedi, M.R. Movahed, The Southern Arizona VA Health Care System, AZ, USA

THIAMIN SUPPLEMENTATION IN PATIENTS WITH CHRONIC HEART FAILURE RECEIVING FULL MEDICAL TREATMENT
M. Mousavi, S. Namazi, M.R. Avadi Khatam-al-Anbia Hospital, Iran

P508   Poster Session
ARRHYTHMIAS AND ANTIARRHYTHMIC DRUG THERAPY: BASIC AND CLINICAL

A STRUCTURED AMIODARONE PROTOCOL FOR THE MANAGEMENT OF POST OPERATIVE ATRIAL FIBRILLATION IS EQUIVALENT TO INDIVIDUALIZED PHYSICIAN MANAGEMENT
M.J. Shih, M.G. Parikh, A. Khandelwal, R.S.D. Higgins, K. Krishnan, Rush University Medical Center, Chicago, IL, USA

THE PREVALENCE OF INTRA-VENTRICULAR CONDUCTION DELAY IN ATRIAL FIBRILLATION
E.A. Charaf, B.S. Abi-Saleh, P. Sultani, B. Omar, S. Verma, University of South Alabama, Mobile, Alabama, USA

SLOWING HEART RATE REDUCES INCIDENCE OF VENTRICULAR FIBRILLATION DURING ACUTE MYOCARDIAL INFARCTION - EXPERIMENTAL STUDY
L. Katsaros, N. Diakos, I. Pozios, E. Tseliou, K. Malliaras, C. Pantsios, S. Sventzouri, N. Michelinakis, J. Terrovitis, J. Nanas, University of Athens, Greece

ORAL ASCORBIC ACID IS EFFECTIVE IN THE PREVENTION OF ATRIAL FIBRILLATION AFTER CORONARY ARTERY BYPASS GRAFTING
M. Mousavi, M. Eslami, R. Sattarzadeh Badkoubeh, H. Radmehr, M. Salehi, N. Tavakoli, M.R. Avadi, Tehran Heart Center,Tehran University of Medical Sciences, Tehran, Iran

ASSOCIATION OF WARFARIN USE WITH CHADS2 SCORE IN 441 PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION AND NO CONTRAINDICATIONS TO WARFARIN
H.M. Lai, W.S. Aronow, H.V. Desai, K. Gandhi, S. Bakerywala, J. Laimuanpuii, M. Sharma, S.J. Peterson, New York Medical College, Valhalla, NY, USA

MULTIFACTORIAL QT INTERVAL PROLONGATION: THE RISK OF POLYPHARMACY
G.C. Digby, A.R. Perez Riera, R. Barbosa Barros, L. de Sousa Belem, C. Fong, M. Methot, F. Femenia, A. Baranchuk Department of Cardiology, Kingston General Hospital, Queen's University, Kingston, ON, Canada

WHAT ARE THE RISK FACTORS FOR DEVELOPING ATRIAL FIBRILLATION IN HIV INFECTED PATIENTS?
Y. Elnahar, J. Daoko, N. Gupta, F. Shamoon, A. Al-dehneh, Seton Hall University, Newark, NJ, USA

P509     Poster Session
ADVANCES IN CARDIAC SURGERY

SELECTIVE MITOCHONDRIAL TRANSLOCATION OF PHOSPHORYLATED PKCÅ IN VIABLE MYOCYTES OVEREXPRESSING UROCORTIN AFTER CARDIOPLEGIC ARREST AND REPERFUSION
C. Chen-Scarabelli, S. Saravolatz, L.D. Saravolatz II, G.M. Scarabelli, G. Chen, J. Di Rezze, L. Saravolatz, T.M. Scarabelli, St John Hospital, Wayne State University, Detroit, MI, USA

COMPARISON OF CORONARY ARTERY BYPASS GRAFTING VERSUS DRUG-ELUTING IMPLANTATION
P.P. Pollice, S.E. Saad, P.F. Pollice, F.A. Fabiani University of Berne, Switzerland

LOWER TREND IN THE NATIONWIDE IN-HOSPITAL MORTALITY OF PATIENTS UNDERGOING CORONARY BYPASS SURGERY (CABG) IN THE UNITED STATES
M.R. Movahed, R.Ramaraj, M. Hashemzadeh, University of Arizona Sarver Heart Center, Tucson, AR, USA

CAROTID INTIMA-MEDIA THICKNESS BY B-MODE ULTRASOUND AS SURROGATE OF CORONARY ATHEROSCLEROSIS
M. Amato, P. Montorsi, A.L. Ravani, S. Galli, P.M. Ravagnani, E. Tremoli, D. Baldassarre, Monzino Cardiology Center, IRCCS, Italy

PREVIOUS PERCUTANEUS CORONARY STENTING: A NEW RISK FACTOR IN CARDIAC SURGERY
J. Rubio, J. Sierra, L. Reija, B. Adrio, J. Garcia-Carro, J.M. Martinez-Cereijo, C. Delgado, Universitary Hospital Santiago de Compostela, Santiagio de Compostela, Spain

EFFECT OF CABG ON QT INTERVAL DISPERSION AS A MEASURE OF INHOMOGENEITY IN VENTRICULAR REPOLARIZATION
M. Nourizadeh, M. Alasti, S. Bahadoran, M. Asadmoghadam Department of Cardiology, Imam Khomeini Hospital, Jondishapour University of Medical Sciences, Ahwaz, Iran

REVASCULARIZATION OUTCOMES ON THE JOINT CARDIOLOGY-CARDIOTHORACIC MULTIDISCIPLINARY TEAM (MDT) MEETING
W.K. Choo, R.A. Amersey, Whipps Cross University Hospital, London, UK

ASSESSMENT OF KIDNEY FUNCTION BY CYSTATIN C IN PATIENTS, AFTER CORONARY ARTERY BYPASS GRAFTING
M. Ster, T. Pintar, M. Tesovnik, J. Osredkar, M. Skitek University Medical Centre, Ljubljana, Slovenia

P510      Poster Session
CARDIAC TRANSPLANTATION

THE USE OF IVUS FOR DIAGNOSIS AND MONITORING OF CARDIAC ALLOGRAFT VASCULOPATHY BY CARDIAC TRANSPLANT CENTERS IN THE UNITED STATES
E. Panczyk, J.C. Copeland, M.R. Movahed, University of Arizona Sarver Heart Center, Tucson, AR, USA

PROTAMINE CAN BE SAFELY ADMINISTERED FOR HEPARIN REVERSAL FOLLOWING IVUS IN CARDIAC TRANSPLANT PATIENTS
R. Arsanjani, A. Khitri, M. Hashemzadeh, M.R. Movahed, The Southern Arizona VA Health Care System, Tucson, AZ, USA

CNI - FREE IM IN CARDIAC TRANSPLANTATION - A SINGLE CENTER EXPERIENCE
M. Kondruweit, R. Tandler, M. Weyand, University of Erlangen, Bavaria, Germany